Clinical trial of phototherapy and vorinostat in the treatment of cutaneous T-cell lymphoma

Clinical trial of phototherapy and vorinostat in the treatment of cutaneous T-cell lymphoma - Phototherapy and vorinostat in CTCL

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010246

Enrollment

Registered

2015-11-30

Start date

2012-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous T-cell lymphoma

Interventions

Phototherapy and vorinostat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed stage 1B to 4 CTCL refractory to phtotherapy. 2. Patients were older than 19 years with Eastern Cooperative Oncology Group performance status grades of 0 to 2 and adequate organ function.

Exclusion criteria

Exclusion criteria: 1. women who were pregnant or lactating or those having known central nervous system involvement or any other malignant disease.

Design outcomes

Primary

Measure	Time frame
Feasibility	—

Countries

Japan

Contacts

Public ContactToshihisa Hamada

Okayama University Hospital Dermatology

t-hamada@cc.okayama-u.ac.jp086-235-7282

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026